Can diabetes management programs create sustained improvements in disease outcomes?
- Diabetes Has Gotten Pretty Darn Complicated. Skolnik, Neil; Grover, Anupriya // Clinical Diabetes;Summer2015, Vol. 33 Issue 3, p114
The author reflects on how educational programs have not evolved at the same rate as the complexity of the medical treatment for diabetes. Topics discussed include the challenge for those in diabetes education to figure out how to deliver the best possible programs to the largest number of...
- Management of Type 2 Diabetes. // New England Journal of Medicine;1/17/2008, Vol. 358 Issue 3, p293
The article asks readers to review treatment options in the management of type 2 diabetes discussed in this issue and to vote on the best option.
- Play of Chance Versus Concerns Regarding Dipeptidyl Peptidase-4 Inhibitors: Heart Failure and Diabetes. Sanon, Vani P.; Sanon, Saurabh; Pham, Son V.; Chilton, Robert // Clinical Diabetes;Summer2014, Vol. 32 Issue 3, p121
The article examines the occurrence of heart failure syndrome in diabetes based on the result of clinical trials of cardiovascular (CV) disease patients who were given dipeptidyl peptidase-4 (DPP-4). The first trial evaluated the safety and efficacy of the saxagliptin in patients with diabetes...
- Metformin and Chronic Renal Impairment: A Story of Choices and Ugly Ducklings. Heaf, James G.; van Biesen, Wim // Clinical Diabetes;Summer2011, Vol. 29 Issue 3, p97
The article reports that the ugly duckling metformin has great potential in diabetic patients with chronic renal impairment if it is applied correctly. Majority of guidelines do not advise the use of metformin in uremia because of an enhanced risk for lactic acidosis. It is also stated that...
- Evaluation of Blood Glucose Monitoring Data Significantly Changes Therapeutic Choices Made by Primary Care Physicians for Patients with Type 2 Diabetes Mellitus. Polonsky, William; Wagner, Robin // Diabetes;Jun2007 Supplement 1, Vol. 56, pA527
The article presents the results of a study on the therapeutic decisions of primary care physicians (PCPs) after the evaluation of self-monitoring blood glucose (SMBG) data for patients with type 2 diabetes in the U.S. 13.3% of the PCPs were able to identify glycemic abnormalities correctly....
- Management of Type 2 Diabetes: What Is the Next Step After Metformin? Lahiri, Sharon W. // Clinical Diabetes;Spring2012, Vol. 30 Issue 2, p72
The article presents a case study of a 67-year-old African- American man who was diagnosed with type 2 diabetes. It is reported that, metformin drug was initially given to the man when he was diagnosed with the diabetes through laboratory testing, and eventually his dosage has been increased to...
- Disease Management Programs for Type 2 Diabetes in Germany--A Systematic Literature Review Evaluating Effectiveness. Fuchs, Sabine; Henschke, Cornelia; Blümel, Miriam; Busse, Reinhard; Mengersen, Rudolf // Deutsches Aerzteblatt International;2/20/2015, Vol. 112 Issue 8, p136
No abstract available.
- Diabetes policy will cut GP workload. // Pulse;6/23/2003, Vol. 63 Issue 25, p4
Reports on a government policy to give all patients with type 2 diabetes structured education on managing the disease in Great Britain.
- Pathogenesis of Type 2 Diabetes: Implications for Metformin. DeFronzo, R.A. // Drugs;Dec1999 Supplement 1, Vol. 58 Issue 6, p29
Discusses the implications of the pathogenesis of type 2 diabetes for metformin. Insulin resistance in type 2 diabetes mellitus individuals; Defects in insulin action; Information on the initial therapeutic approach in type 2 diabetes mellitus patients.